Universe Pharmaceuticals (UPC) Inventory (2020 - 2025)
Universe Pharmaceuticals (UPC) reported Inventory of $2.5 billion for Q3 2025, up 43.33% on a YoY basis from $1.7 billion in Q3 2024, and up 43.33% sequentially from $1.7 billion in Q3 2024.
Universe Pharmaceuticals (UPC) Inventory (2020 - 2025) Analysis & Trends
Universe Pharmaceuticals (UPC) has 6 years of Inventory data on file, last reported at $2.5 billion in Q3 2025.
- For the quarter ending Q3 2025, Inventory rose 43.33% year-over-year to $2.5 billion; the trailing twelve-month figure through Sep 2025 stood at $2.5 billion (up 43.33% YoY), and the FY2025 full-year result was $2.5 billion, up 43.33% from the prior year.
- Inventory rose to $2.5 billion in Q3 2025, from $1.7 billion in the prior quarter.
- In the past five years, Inventory ranged from a high of $2.5 billion in Q3 2025 to a low of $103653.0 in Q1 2022.
- A 5-year average of $529.5 million and a median of $2.5 million in 2021 frame the typical range for Inventory.
- Across the five-year window, Inventory slumped 100.0% in 2021 and soared 51856.8% in 2024, its largest moves.
- Tracing UPC's Inventory over 5 years: stood at $2.7 million in 2021, then declined by 19.42% to $2.2 million in 2022, then soared by 51.52% to $3.3 million in 2023, then soared by 51856.8% to $1.7 billion in 2024, then soared by 43.33% to $2.5 billion in 2025.
- Business Quant data shows UPC's Inventory at $2.5 billion in Q3 2025, $1.7 billion in Q3 2024, and $368960.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 178.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.49 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 76.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.49 Bn |
| Sep 30, 2024 | 1.74 Bn |
| Mar 31, 2024 | 368,960.00 |
| Sep 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 207,719.00 |
| Sep 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 103,653.00 |
| Sep 30, 2021 | 2.74 Mn |
| Sep 30, 2020 | 1,906.23 Bn |